Inion Receives 510(k) Marketing Clearance To Sell Its Biodegradable Graft Containment Systems In The USA For Spinal Fusion Procedures
Jul 22nd 2008Drug InformationBones
Inion (LSE: IIN), the company focused on the development and commercialisation of novel biodegradable medical implants, announces it has received 510(k) marketing clearance from the US Food and Drug Administration (FDA) for its biodegradable graft containment systems for spinal fusion procedures.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
